AXIM Biotechnologies, Inc. (AXIM)

AXIM Biotechnologies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	4	5	5	60	54	23
Market Cap Growth	-37.47%	-12.57%	-91.35%	10.19%	135.52%	-48.38%
Enterprise Value	11	10	11	66	59	29
Last Close Price	0.01	0.02	0.03	0.43	0.43	0.36
PE Ratio	-	-0.48	-0.69	-3.55	-7.09	-3.44
PS Ratio	50.88	114.26	581.91	987.63	-	-
PB Ratio	-0.43	-0.59	-1.07	-25.54	34.61	-3.40
P/FCF Ratio	-1.62	-4.38	-2.52	-23.63	-16.36	-4.57
P/OCF Ratio	-1.62	-4.38	-2.53	-24.01	-16.85	-4.57
EV/Sales Ratio	124.39	260.76	1201.77	1086.71	-	-
EV/EBITDA Ratio	-4.45	-4.43	-2.52	-11.15	-12.02	-9.36
EV/EBIT Ratio	-3.67	-3.75	-2.29	-8.20	-11.98	-9.35
EV/FCF Ratio	-4.58	-10.00	-5.20	-26.00	-17.90	-5.77
Debt / Equity Ratio	-0.90	-0.77	-1.18	-2.89	4.05	-0.75
Debt / FCF Ratio	-3.41	-5.72	-2.77	-2.67	-1.91	-1.01
Asset Turnover	0.02	0.01	0.00	0.01	-	-
Quick Ratio	0.02	0.03	0.01	0.18	0.31	0.21
Current Ratio	0.02	0.03	0.03	0.25	0.48	0.48
Return on Assets (ROA)	-38.30%	-41.26%	-60.99%	-60.17%	-47.56%	-102.77%
Return on Capital (ROIC)	-	-	-110.15%	-81.29%	-99.14%	-
Earnings Yield	-128.71%	-178.50%	-120.88%	-26.85%	-11.83%	-28.02%
FCF Yield	-45.10%	-22.82%	-39.75%	-4.23%	-6.11%	-21.90%
Buyback Yield / Dilution	-21.87%	-37.60%	-25.79%	-19.16%	-78.19%	-8.14%
Total Shareholder Return	-21.87%	-37.60%	-25.79%	-19.16%	-78.19%	-8.14%

Source: S&P Capital IQ. Standard template.